Compare Quest Diagnostics Inc (DGX) vs Ishares Msci Thailand Etf (THD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Ishares Msci Thailand Etf — how do they compare? Quest Diagnostics Inc trades at $205.45 (market cap $22.80B), while Ishares Msci Thailand Etf trades at $72.74. The key difference: Quest Diagnostics Inc pays a 1.67% dividend while Ishares Msci Thailand Etf pays none, and Ishares Msci Thailand Etf is trading nearer its 52-week high, Quest Diagnostics Inc nearer its low. Which is the better fit depends on your goals.
| DGX | THD | |
|---|---|---|
Market Cap | $22.80B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $216.02 | $75.05 |
52-Week Low | $166.42 | $53.63 |
Enterprise Value | $28.82B | — |
Dividend Yield | 1.67% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $207.35, showing minimal daily movement with a slight decline of 0.04%. The stock maintains a bullish technical stance with recent earnings beats and analyst consensus pointing to upside potential. Recent developments include New York State approval for Haystack MRD testing and strong momentum across diagnostic channels. Revenue growth accelerated to $11.04 billion in 2025 with consistent profitability margins around 9%.
DGX presents a balanced investment case with 38% analyst buy ratings and a $227.75 price target suggesting 10% upside. The company demonstrates steady revenue growth and operational efficiency, though elevated debt levels and policy risks require monitoring. Second quarter earnings on July 23, 2026, will be crucial for validating current momentum and growth trajectory.
THD trades at $72.33, down 0.25% on the day, with technical indicators showing a bullish trend from moving averages and neutral oscillators. The stock faces key support at $72 and resistance at $73. A dividend of $1.71 is scheduled for payment on June 18, 2026. Recent news highlights THD's strong performance as an ASEAN ETF, driven by exposure to Delta Electronics and AI hardware plays, though this concentration introduces vulnerability to profit-taking.
The outlook for THD is cautiously optimistic given its technical strength and thematic tailwinds from AI, but risks include over-reliance on single holdings and regional economic sensitivity. Investors should weigh the ETF's recent outperformance against potential volatility from geopolitical and monetary policy shifts affecting Asian markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Ishares Msci Thailand Etf
THD is a country-specific ETF that tracks the performance of the Thai equity market. It provides broad exposure to Thailand's economy across sectors like electronics, energy, and financials, with top holdings such as Delta Electronics.
Read more on THD →
